Zim Laboratories credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023


123	123	112	106	59.6
79.6	79.6	110	95.9	52.0
0.42×	0.42×	0.44×	0.45×	0.30×
0.27×	0.27×	0.43×	0.40×	0.26×
4.10×	4.10×	2.57×	2.57×	1.15×
2.82×	2.65×	2.51×	2.32×	1.00×
0.76×	0.76×	2.07×	3.67×	6.19×
29.3%	29.3%	30.8%	30.8%	22.9%
0.50×	0.42×	0.44×	—	—
0.53×	1.13×	1.65×	2.00×	2.00×
−0.53×	1.62×	2.58×	4.00×	7.00×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZIMLAB₹136.54

Zim Laboratories Limited

· Pharma & Health

₹ CrorePeersANUHPHR VALIANTLAB AHCL ALBERTDAVD WANBURY HALEOSLABS BAJAJHCARE THEMISMEDMcap ₹730 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Total Debt	59.6	106.4	112.2	123.0	123.0
Net Debt	52.0	95.9	109.7	79.6	79.6
Total Debt/Equity	0.30	0.45	0.44	0.42	0.42
Net Debt/Equity	0.26	0.40	0.43	0.27	0.27
Total Debt/EBITDA	1.15	2.57	2.57	4.10	4.10
Net Debt/EBITDA	1.00	2.32	2.51	2.65	2.82
Interest Coverage (EBIT/Interest)	6.19	3.67	2.07	0.76	0.76
Total Debt/Total Capital %	22.92	30.82	30.78	29.34	29.34
As Filed — company-reported covenants
Debt/Equity (as filed)	—	—	0.44	0.42	0.50
Debt Service Coverage (as filed)	2.00	2.00	1.65	1.13	0.53
Interest Service Coverage (as filed)	7.00	4.00	2.58	1.62	-0.53

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.